Species: Veillonella dispar (HMT-0160) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0160: [Body Sites Data]
[Taxon Description]
| Life Page: Veillonella dispar
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.14 | 0.14 | 0.11 | 0.18 | 0.24 | 0.35 | 1.65 | 3.28 | 1.60 | 2.10 | 0.11 | 0.01 | 0 | 0.17 | 0 | 0.02 | 0.02 | 0.04 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.04 | 0.02 | 0.01 | 0.01 | 0.03 | 0.35 | 0.28 | 0.71 | 0.20 | 0.58 | 0 | 0 | 0 | 0.17 | 0 | 0 | 0 | 0 |
| 90thp | 0.32 | 0.31 | 0.25 | 0.53 | 0.56 | 0.35 | 3.32 | 7.37 | 3.49 | 3.85 | 0.21 | 0.01 | 0.01 | 0.17 | 0 | 0.07 | 0.02 | 0.02 |
| Stdev | 0.11 | 0.15 | 0.19 | 0.24 | 0.28 | 0 | 1.88 | 3.19 | 1.46 | 1.35 | 0.39 | 0.02 | 0.01 | 0 | 0 | 0.05 | 0.07 | 0.36 |
| Prev(%) | 16.67 | 31.65 | 4.17 | 40.00 | 36.84 | 100.00 | 87.50 | 100.00 | 86.36 | 99.29 | 3.08 | 0 | 0 | 0 | 0 | 0 | 0 | 2.40 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
Notes:
reads equally close to V. dispar strain DSM 20735 and V. parvula clone BU083 were assigned to V. dispar
reads equally close to V. parvula clone _X002 and V. dispar clone _X031 were assigned to V. parvula
reads equally close to V. dispar strain DSM 20735 and V. parvula clone BU083 were assigned to V. dispar
reads equally close to V. parvula clone _X002 and V. dispar clone _X031 were assigned to V. parvula
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.53 | 0.42 | 0.34 | 0.89 | 2.55 | 4.54 | 3.63 | 3.45 | 6.08 | 0.02 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0.04 | 0.28 | 0.98 | 0.85 | 0.67 | 1.03 | 0 |
| 90thp | 1.53 | 1.21 | 1.28 | 2.15 | 6.79 | 9.75 | 7.03 | 8.11 | 12.61 | 0.05 |
| Stdev | 0.85 | 0.52 | 0.62 | 1.42 | 2.63 | 3.69 | 2.92 | 3.03 | 4.49 | 0.04 |
| Prev(%) | 79.22 | 85.71 | 76.62 | 94.81 | 98.70 | 97.40 | 100.00 | 100.00 | 100.00 | 25.97 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to V. atypica, V. denticariosi, V. dispar, V. parvula, and V. rogosae were assigned one-fifth to each taxon.
Reads equally close to V. atypica, V. denticariosi, V. dispar, V. parvula, and V. rogosae were assigned one-fifth to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.80 | 0.75 | 0.28 | 0.57 | 1.17 | 2.32 | 1.55 | 1.41 | 2.01 | 0.01 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.07 | 0.08 | 0 | 0.08 | 0.32 | 0.87 | 0.55 | 0.46 | 0.81 | 0 |
| 90thp | 2.05 | 1.71 | 0.78 | 1.40 | 2.31 | 3.92 | 2.69 | 2.61 | 3.27 | 0.01 |
| Stdev | 1.11 | 0.86 | 0.59 | 0.56 | 0.78 | 1.19 | 0.85 | 0.87 | 0.97 | 0.04 |
| Prev(%) | 98.65 | 100.00 | 91.22 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 29.37 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
Notes:
Reads equidistant to HMT-158 and HMT-160 were assigned to each taxon in proportion to the abundance of HMT-158 and HMT-160 individually at these sites (AKE,BMU,HPA,LAF,PTO,SAL,THR,TDO).
Reads equidistant to HMT-160 and HMT-161 were assigned to each taxon in proportion to the abundance of HMT-160 and HMT-161 individually at these sites (ANA,LRC,RAF,RRC,SUBP,SUPP).
Reads equidistant to HMT-158 and HMT-160 were assigned to each taxon in proportion to the abundance of HMT-158 and HMT-160 individually at these sites (AKE,BMU,HPA,LAF,PTO,SAL,THR,TDO).
Reads equidistant to HMT-160 and HMT-161 were assigned to each taxon in proportion to the abundance of HMT-160 and HMT-161 individually at these sites (ANA,LRC,RAF,RRC,SUBP,SUPP).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.34 | 0.09 | 0.68 | 1.22 | 3.11 | 5.13 | 4.72 | 4.50 | 6.52 | 0.12 | 0.09 | 0.05 | 0.22 | 0.28 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.02 | 0 | 0.01 | 0.08 | 0.41 | 0.85 | 0.79 | 0.63 | 0.94 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.71 | 0.22 | 1.84 | 2.63 | 7.37 | 11.20 | 9.34 | 10.01 | 12.71 | 0.35 | 0.11 | 0.08 | 0.58 | 0.77 | 0 | 0 | 0 | 0 |
| Stdev | 0.83 | 0.12 | 1.85 | 1.49 | 3.05 | 4.26 | 3.69 | 4.19 | 4.65 | 0.32 | 0.45 | 0.21 | 0.50 | 0.71 | 0 | 0 | 0 | 0 |
| Prev(%) | 99.34 | 97.35 | 93.01 | 99.31 | 99.33 | 96.15 | 98.81 | 100.00 | 100.00 | 54.00 | 41.95 | 32.30 | 47.70 | 50.69 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
Reads equidistant to HMT-160 and HMT-161 were assigned to each taxon in proportion to the abundance of HMT-160 and HMT-161 individually at these sites (AKE,BMU,HPA,SAL,SUBP,SUPP).
Neither HMT-160 nor HMT-161 were present singularly so these reads were split evenly at this site (ANA).
Because HMT-161 is not present individually, all equidistant reads were assigned to HMT-160 at this body site (RRC).
Some of the reads equidistant from these taxa (160-161-524) are included in HMT-160 because they are too close to differentiate at these sites (SAL,THR,TDO).
Reads equidistant to HMT-160 and HMT-161 were assigned to each taxon in proportion to the abundance of HMT-160 and HMT-161 individually at these sites (AKE,BMU,HPA,SAL,SUBP,SUPP).
Neither HMT-160 nor HMT-161 were present singularly so these reads were split evenly at this site (ANA).
Because HMT-161 is not present individually, all equidistant reads were assigned to HMT-160 at this body site (RRC).
Some of the reads equidistant from these taxa (160-161-524) are included in HMT-160 because they are too close to differentiate at these sites (SAL,THR,TDO).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.39 | 0.25 | 0.82 | 1.95 | 5.15 | 4.74 | 5.84 | 4.98 | 8.60 | 0.08 | 0 | 0.27 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.02 | 0.01 | 0 | 0.11 | 0.10 | 0.59 | 0.35 | 0.13 | 0.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.87 | 0.57 | 2.53 | 4.80 | 12.70 | 10.03 | 14.22 | 13.12 | 19.54 | 0.21 | 0 | 0.37 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 1.05 | 0.46 | 1.46 | 2.44 | 5.65 | 4.38 | 5.71 | 5.90 | 7.96 | 0.20 | 0 | 1.27 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 98.52 | 99.51 | 87.41 | 96.53 | 95.65 | 99.70 | 98.44 | 96.59 | 99.76 | 54.02 | 0 | 41.36 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
Notes:
Reads equally close to HMT 160, 161, and 524 were assigned one-third to each taxon.
Reads equally close to HMT 160, 161, and 887 were assigned one-third to each taxon.
Reads equally close to HMT 158, 160, and 161 were distributed equally among taxa.
Reads equally close to HMT 160, 161, and 524 were assigned one-third to each taxon.
Reads equally close to HMT 160, 161, and 887 were assigned one-third to each taxon.
Reads equally close to HMT 158, 160, and 161 were distributed equally among taxa.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 1.35 | 2.15 | 0.86 | 1.25 | 1.01 | 0.88 | 1.48 | 0.99 | 1.35 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0.01 | 0.11 | 0.01 | 0.07 | 0.16 | 0.08 | 0.27 | 0.12 | 0.01 | 0 |
| 90thp | 4.07 | 4.53 | 3.24 | 2.95 | 1.90 | 2.19 | 2.58 | 2.47 | 2.80 | 0.01 |
| Stdev | 2.56 | 2.27 | 1.71 | 1.92 | 0.68 | 0.83 | 0.95 | 0.95 | 1.13 | 0.01 |
| Prev(%) | 98.65 | 100.00 | 97.67 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 15.00 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.02 | 0.03 | 0.01 | 0.20 | 0.70 | 1.51 | 4.07 | 5.58 | 4.68 | 7.13 | 0.07 | 0 | 0 | 0.03 | 0.10 | 0 | 0.06 | 0.05 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 1.51 | 0.17 | 1.13 | 0.28 | 0.03 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 |
| 90thp | 0.05 | 0.04 | 0.03 | 0.42 | 2.04 | 1.51 | 8.43 | 12.89 | 11.15 | 14.88 | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.02 |
| Stdev | 0.05 | 0.24 | 0.02 | 0.53 | 1.19 | 0 | 3.82 | 5.57 | 4.82 | 5.70 | 0.68 | 0 | 0.02 | 0 | 0.34 | 0 | 0.42 | 0.69 |
| Prev(%) | 37.50 | 31.82 | 25.00 | 47.06 | 75.00 | 100.00 | 87.50 | 100.00 | 96.00 | 90.61 | 7.21 | 0 | 3.13 | 100.00 | 9.09 | 0 | 8.08 | 13.64 |
